GLUE

GLUE Stock-Based Compensation

$20.59MTTM · USD

Period ending:

GLUE FY Stock-Based CompUSD
GLUE FY Stock-Based Comp2019-12-31: $0.002020-12-31: $354.00K2021-12-31: $5.20M2022-12-31: $11.66M2023-12-31: $16.67M2024-12-31: $18.13M2025-12-31: $18.87M$18.87M$0.00
2019-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

GLUE stock-based compensation history

Non-cash compensation expense paid in equity. The available annual fiscal periods series contains 7 observations from Dec 31, 2019 to Dec 31, 2025.

Monte Rosa Therapeutics Inc Stock-Based Compensation — Annual fiscal periods (USD)
Period endingStock-Based Compensation (USD)
18,865,000
18,126,000
16,669,000
11,664,000
5,200,000
354,000
0

Compare stock-based compensation

All GLUE financial metrics · GLUE stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.